Medtronic has obtained the European CE-Mark for its insulin delivery device called MiniMed 670G hybrid closed loop system which has been designed to treat type 1 diabetes patients aged seven years and above.

The system can automate and personalise basal insulin delivery. It features Medtronic’s SmartGuard technology and Guardian Sensor 3, a continuous glucose monitor (CGM).

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Together, the technology and CGM enable self-adjustment of basal insulin delivery in order to provide protection from both high and low levels.

“The system can automate and personalise basal insulin delivery. It features Medtronic’s SmartGuard technology and Guardian Sensor 3, a continuous glucose monitor.”

Medtronic Advanced Insulin Management division president Alejandro Galindo said: “The MiniMed 670G system advances our ability to automatically suspend and resume insulin delivery to the next level by automating self-adjusting basal insulin delivery every five minutes based on sensor glucose values – providing the most advanced algorithm available to deliver leading clinical outcomes.”

Medtronic, in collaboration with strategic technology partner IBM Watson Health, has also launched the Sugar.IQ smart diabetes management app.

Intended to simplify and improve daily management of the condition, the app is powered by IBM Watson’s artificial intelligence (AI) and analytic technologies.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Sugar.IQ continuously tracks the response of glucose level to food intake, insulin dosages and daily routines, among other factors, in turn aiding patients to make daily management decisions.

Medtronic is providing the app to users of its Guardian Connect system, a smart CGM device for diabetes patients using multiple daily injections (MDI). The system offers actionable tools to manage high and low glucose levels.

The Sugar.IQ assistant app is available for iOS-based mobile devices in the US.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact